305 related articles for article (PubMed ID: 11900279)
21. D-chiro-inositol glycans in insulin signaling and insulin resistance.
Larner J; Brautigan DL; Thorner MO
Mol Med; 2010; 16(11-12):543-52. PubMed ID: 20811656
[TBL] [Abstract][Full Text] [Related]
22. Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats.
Fonteles MC; Almeida MQ; Larner J
Horm Metab Res; 2000 Apr; 32(4):129-32. PubMed ID: 10824707
[TBL] [Abstract][Full Text] [Related]
23. A stereospecific myo-inositol/D-chiro-inositol transporter in HepG2 liver cells. Identification with D-chiro-[3-3H]inositol.
Ostlund RE; Seemayer R; Gupta S; Kimmel R; Ostlund EL; Sherman WR
J Biol Chem; 1996 Apr; 271(17):10073-8. PubMed ID: 8626564
[TBL] [Abstract][Full Text] [Related]
24. Effect of pinitol treatment on insulin action in subjects with insulin resistance.
Davis A; Christiansen M; Horowitz JF; Klein S; Hellerstein MK; Ostlund RE
Diabetes Care; 2000 Jul; 23(7):1000-5. PubMed ID: 10895854
[TBL] [Abstract][Full Text] [Related]
25. Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation.
Stull AJ; Thyfault JP; Haub MD; Ostlund RE; Campbell WW
Metabolism; 2008 Nov; 57(11):1545-51. PubMed ID: 18940392
[TBL] [Abstract][Full Text] [Related]
26. Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K/Akt signaling pathway.
Gao YF; Zhang MN; Wang TX; Wu TC; Ai RD; Zhang ZS
Mol Cell Endocrinol; 2016 Sep; 433():26-34. PubMed ID: 27212205
[TBL] [Abstract][Full Text] [Related]
27. Adipose tissue glycogen synthase activation by in vivo insulin in spontaneously insulin-resistant and type 2 (non-insulin-dependent) diabetic rhesus monkeys.
Ortmeyer HK; Bodkin NL; Hansen BC
Diabetologia; 1993 Mar; 36(3):200-6. PubMed ID: 8462768
[TBL] [Abstract][Full Text] [Related]
28. In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat.
Pak Y; Hong Y; Kim S; Piccariello T; Farese RV; Larner J
Mol Cells; 1998 Jun; 8(3):301-9. PubMed ID: 9666467
[TBL] [Abstract][Full Text] [Related]
29. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys.
Ortmeyer HK; Bodkin NL; Hansen BC
Am J Physiol; 1993 Sep; 265(3 Pt 2):R552-8. PubMed ID: 8214144
[TBL] [Abstract][Full Text] [Related]
30. In vivo insulin regulation of skeletal muscle glycogen synthase in calorie-restricted and in ad libitum-fed rhesus monkeys.
Ortmeyer HK
J Nutr; 2001 Mar; 131(3):907S-912S. PubMed ID: 11238784
[TBL] [Abstract][Full Text] [Related]
31. Inositol and human reproduction. From cellular metabolism to clinical use.
Milewska EM; Czyzyk A; Meczekalski B; Genazzani AD
Gynecol Endocrinol; 2016 Sep; 32(9):690-695. PubMed ID: 27595157
[TBL] [Abstract][Full Text] [Related]
32. Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.
Nestler JE; Jakubowicz DJ; Iuorno MJ
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1295-8. PubMed ID: 11117673
[TBL] [Abstract][Full Text] [Related]
33. Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance.
Larner J; Craig JW
Diabetes Care; 1996 Jan; 19(1):76-8. PubMed ID: 8720541
[No Abstract] [Full Text] [Related]
34. A thiazolidinedione improves in vivo insulin action on skeletal muscle glycogen synthase in insulin-resistant monkeys.
Ortmeyer HK; Bodkin NL; Haney J; Yoshioka S; Horikoshi H; Hansen BC
Int J Exp Diabetes Res; 2000; 1(3):195-202. PubMed ID: 11467410
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
36. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
Nestler JE; Jakubowicz DJ; Reamer P; Gunn RD; Allan G
N Engl J Med; 1999 Apr; 340(17):1314-20. PubMed ID: 10219066
[TBL] [Abstract][Full Text] [Related]
37. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
Gateva A; Unfer V; Kamenov Z
Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
[TBL] [Abstract][Full Text] [Related]
38. From Myo-inositol to D-chiro-inositol molecular pathways.
Kiani AK; Paolacci S; Calogero AE; Cannarella R; Di Renzo GC; Gerli S; Della Morte C; Busetto GM; De Berardinis E; Del Giudice F; Stuppia L; Facchinetti F; Dinicola S; Bertelli M
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2390-2402. PubMed ID: 33755975
[TBL] [Abstract][Full Text] [Related]
39. Lack of defect in insulin action on hepatic glycogen synthase and phosphorylase in insulin-resistant monkeys.
Ortmeyer HK; Bodkin NL
Am J Physiol; 1998 Jun; 274(6):G1005-10. PubMed ID: 9696698
[TBL] [Abstract][Full Text] [Related]
40. A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes.
Maurizi AR; Menduni M; Del Toro R; Kyanvash S; Maggi D; Guglielmi C; Pantano AL; Defeudis G; Fioriti E; Manfrini S; Pozzilli P
Acta Diabetol; 2017 Apr; 54(4):361-365. PubMed ID: 28039583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
